2024-10-21 03:39:48
Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting
Corporate/ 2023-07-24
Bridge Biotherapeutics to Present Update...

The abstract of BBT-207 preclinical studies is now available on the AACR website Preclinical data suggests that BBT-207 may have the potenti...

Ark Biopharmaceutical and Calibr, a Division of  Scripps Research, Announce Co-development Collaboration on AK0705, a Potential First-in-Class Drug for Treating a Broad Spectrum of Respiratory Diseases, Including COPD
Health/ 2023-07-22
Ark Biopharmaceutical and Calibr, a Divi...

Ark Biopharmaceutical will lead development activities for AK0705 with the goal of initiating clinical studies in 2024.

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release